Identification of human cytochrome P-450 isoforms involved in metabolism of R(+)- and S(-)-gallopamil: Utility of in vitro disappearance rate

Drug Metabolism and Disposition

Volumn 27, Issue 11, 1999, Pages 1254-1259

  Suzuki, Akio ^a,b   Iida, Izumi ^a,b   Tanaka, Fumie ^a   Akimoto, Masayuki ^a   Fukushima, Kiyomi ^a   Tani, Masayoshi ^b   Ishizaki, Takashi ^b   Chiba, Kan ^c  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 ISOENZYME; GALLOPAMIL; KETOCONAZOLE; TESTOSTERONE; TROLEANDOMYCIN; VERAPAMIL;

ARTICLE; DRUG CLEARANCE; DRUG METABOLISM; DRUG STRUCTURE; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER METABOLISM; LIVER MICROSOME; PRIORITY JOURNAL;

CYTOCHROME P-450 ENZYME SYSTEM; GALLOPAMIL; HUMANS; ISOENZYMES; MICROSOMES, LIVER; RECOMBINANT PROTEINS; STEREOISOMERISM;

EID: 0032749285     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Bargetzi MJ, Aoyama T, Gonzalez FJ and Meyer UA (1989) Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4. Clin Pharmacol Ther 46:521-527.
2. Birgersson C, Morgan ET, Jörnvall H and von Bahr C (1986) Purification of a desmethylimipramine and debrisoquine hydroxylating cytochrome P-450 from human liver. Biochem Pharmacol 35:3165-3166.
3. Brockmöller J and Roots I (1994) Assessment of liver metabolic function: Clinical implications. Clin Pharmacokinet 27:216-248.
4. Busse D, Cosme J, Beaune P, Kroemer HK and Eichelbaum M (1995) Cytochromes of the P450 2C subfamily are the major enzymes involved in the O-demethylation of verapamil in humans. Naunyn-Schmiedeberg's Arch Pharmacol 353:116-121.
5. Chenery RJ, Oldham HG, Standring P, Norman SJ, Jennings P and Mason PA (1987) Antipyrine metabolism in cultured rat hepatocytes. Biochem Pharmacol 36:3077-3081.
6. Chiba K, Kobayashi K, Manabe K, Tani M, Kamataki T and Ishizaki T (1993a) Oxidative metabolism of omeprazole in human liver microsomes: Congregation with S-mephenytoin 4′-hydroxylation. J Pharmacol Exp Ther 266:52-59.
7. Chiba K, Manabe K, Kobayashi K, Takayama Y, Tani M and Ishizaki T (1993b) Development and preliminary application of a simple assay of S-mephenytoin 4-hydroxylase activity in human liver microsomes. Eur J Clin Pharmacol 44:559-562.
8. Combalbert J, Fahre I, Fabre G, Dalet I, Derancourt J, Cano JP and Maurel P (1989) Metabolism of cyclosporine A. IV. Purification and identification of the rifampicin-inducible human liver cytochrome P-450 (cyclosporin-oxidase) as a product of P-450IIIA gene subfamily. Drug Metab Dispos 17:197-207.
9. Crespi CL (1995) Xenobiotic-metabolizing human cells as tools for pharmacological and toxicological research. Adv Drug Res 26:179-235.
10. Eichelbaum M, Mikus G and Vogelgesang B (1984) Pharmacokinetics of (+)-, (-)-, and (±)-verapamil after intravenous administration. Br J Clin Pharmacol 17:453-458.
11. Gross AS, Mikus G, Ratge D, Wisser H and Eichelbaum M (1997) Pharmacokinetics and pharmacodynamics of the enantiomers of gallopamil. J Pharmacol Exp Ther 281: 1102-1112.
12. Guengerich FP, Martin MV, Beaune PH, Kremers P, Wolff T and Waxman DJ (1986) Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. J Biol Chem 261:5051-5060.
13. Houston JB (1994) Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem Pharmacol 47:1469-1479.
14. Imaoka S, Yamada T, Hiroi T, Hayashi K, Sakaki T, Yabusaki Y and Funae Y (1996) Multiple forms of human P450 expressed in Saccharomyces cerevisiae. Systematic characterization and comparison with those of the rat. Biochem Pharmacol 51:1041-1050.
15. Jacolot F, Simon I, Dreano Y, Beaune P, Riche C and Berthou F (1991) Identification of the cytochrome P-450IIIA family as the enzymes involved in the N-demethylation of tamoxifen in human liver microsomes. Biochem Pharmacol 41:1911-1919.
16. Kobayashi K, Chiba K, Yagi T, Shimada N, Taniguchi T, Horie T, Tani M, Yamamoto T, Ishizaki T and Kuroiwa Y (1997) Identification of cytochrome P450 isoforms involved in citalopram N-demethylation by human liver microsomes. J Pharmacol Exp Ther 280:927-933.
17. Kroemer HK, Gautier JC, Beaune P, Henderson C, Wolf CR and Eichelbaum M (1993) Identification of P450 enzymes involved in metabolism of verapamil in humans. Naunyn-Schmiedeberg's Arch Pharmacol 348:332-337.
18. Kronbach T, Fischer V and Meyer UA (1988) Cyclosporine metabolism in human liver: Identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. Clin Pharmacol Ther 43:630-635.
19. Kronbach T, Mathys D, Umeno M, Gonzalez FJ and Meyer UA (1989) Oxidation of midazolam by human liver cytochrome P450IIIA4. Mol Pharmacol 36:89-96.
20. Leemann T, Transon C and Dayer P (1992) Cytochrome P450TB (CYP2C): A major monooxygenase catalyzing diclofenac 4′-hydroxylation in human liver. Life Sci 52:29-34.
21. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
22. Mutlib AE and Nelson WL (1990a) Pathways of gallopamil metabolism: Regiochemistry and enantioselectivity of the O-demethylation processes. Drug Metab Dispos 18:309-314.
23. Mutlib AE and Nelson WL (1990b) Pathways of gallopamil metabolism: Regiochemistry and enantioselectivity of the N-dealkylation processes. Drug Metab Dispos 18:331-337.
24. Newton DJ, Wang RW and Lu AYH (1995) Cytochrome P450 inhibitors: Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metab Dispos 23:154-158.
25. Peter R, Böcker R, Beaune PH, Iwasaki M, Guengerich FP and Yang CS (1990) Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chem Res Toxicol 3:566-573.
26. Pichard L, Fabre I, Fabre G, Domergue J, Aubert BS, Mourad G and Maurel P (1990a) Cyclosporin A drug interactions: Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes. Drug Metab Dispos 18:595-604.
27. Pichard L, Gillet G, Fabre I, Beluche ID, Bonfils C, Thenot J-P and Maurel P (1990b) Identification of the rabbit and human cytochromes P-450IIIA as the major enzymes involved in the N-demethylation of diltiazem. Drug Metab Dispos 18:711-719.
28. Stieren B, Bühler V, Hege HG, Hollmann M, Neuss H, Schlepper M and Weymann J (1983) Pharmakokinetik und Metabolismus von Gallopamil, in Gallopamil, Pharmakologisches und Klinisches Wirkungsprofil eines Kalziumantagonisten (Kallenbach M and Hopf R eds) pp 90-96, Springer-Verlag, Berlin.
29. Tassaneeyakul W, Birkett DJ, Veronese ME, McManus ME, Tukey RH, Quattrochi LC, Gelboin HV and Miners JO (1993) Specificity of substrate and inhibitor probes for human cytochrome P4501A1 and 1A2. J Pharmacol Exp Ther 265:401-407.
30. Vogelgesang B, Echizen H, Schmidt E and Eichelbaum M (1984) Stereoselective first-pass metabolism of highly cleared drugs: Studies of the bioavailability of L-and D-verapamil examined with a stable isotope technique. Br J Clin Pharmacol 18:733-740.
31. Waxman DJ, Attisano C, Guengerich FP and Lapenson DP (1988) Human liver microsomal steroid metabolism: Identification of the major steroid hormone 6β-hydroxylase cytochrome P-450 enzyme. Arch Biochem Biophys 263:424-436.
32. Weymann J, Bühler V, Hege HG, Müller-Peltzer H, Schenk G, Stieren B and Hollmann M (1989) Metabolism of the calcium antagonist gallopamil in man. Arzneim Forsch/Drug Res 39:605-607.
33. Wrighton SA, Stevens JC, Becker GW and VandenBranden M (1993) Isolation and characterization of human liver cytochrome P450 2C19: Correlation between 2C19 and S-mephenytoin 4′-hydroxylation. Arch Biochem Biophys 306:240-245.
34. Yamano S, Tatsuno J and Gonzalez FJ (1990) The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry 29:1322-1329.
35. Yoshimoto K, Echizen H, Chiba K, Tani M and Ishizaki T (1995) Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers: N-Desisopropylation is mediated mainly by CYP1A2. Br J Clin Pharmacol 39:421-431.
36. Yun C-H, Okerholm RA and Guengerich FP (1993) Oxidation of the antihistaminic drug terfenadine in human liver microsomes: Role of cylochrome P-450 3A(4) in N-dealkylation and C-hydroxylation. Drug Metab Dispos 21:403-409.
37. Zhao X-J, Yokoyama H, Chiba K, Wanwimolruk S and Ishizaki T (1996) Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human liver microsomes and nine recombinant human cytochromes P450. J Pharmacol Exp Ther 279: 1327-1334.